mianserin has been researched along with Peripheral Nerve Diseases in 1 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Excerpt | Relevance | Reference |
---|---|---|
"Mirtazapine (MTZ) is a new and well-tolerated tricyclic antidepressants with both monoaminergic and opioid properties that might favorably influence pain." | 2.73 | Mirtazapine decreases the pain feeling in healthy participants. ( Arnold, P; Deriaz, O; Gobelet, C; Kuntzer, T; Vuadens, P, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnold, P | 1 |
Vuadens, P | 1 |
Kuntzer, T | 1 |
Gobelet, C | 1 |
Deriaz, O | 1 |
1 trial available for mianserin and Peripheral Nerve Diseases
Article | Year |
---|---|
Mirtazapine decreases the pain feeling in healthy participants.
Topics: Adult; Analgesics; Antidepressive Agents, Tricyclic; Cross-Over Studies; Double-Blind Method; Drug A | 2008 |